Piperacillin and Xigris drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Piperacillin (piperacillin sodium) and Xigris (drotrecogin alfa (activated)). Common drug interactions include grand mal convulsion among females and gastrointestinal haemorrhage among males.
The phase IV clinical study analyzes what interactions people have when they take Piperacillin and Xigris. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Piperacillin?
Piperacillin has active ingredients of piperacillin sodium. eHealthMe is studying from 5,597 Piperacillin users. Check the latest studies of Piperacillin.
What is Xigris?
Xigris has active ingredients of drotrecogin alfa (activated). eHealthMe is studying from 3,542 Xigris users. Check the latest studies of Xigris.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
14 people who take Piperacillin and Xigris together, and have interactions are studied.

What are the common drug interactions of Piperacillin and Xigris, by gender? *:
female:
- Grand mal convulsion (a type of generalized seizure that affects the entire brain)
- Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
- Activated partial thromboplastin time prolonged
- Catheter site haemorrhage (bleeding at catheter site)
- Coagulopathy (blood's ability to clot is impaired)
- Infarction (obstruction of the blood supply to an organ or region of tissue)
- Septic shock (shock due to blood infection)
male:
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Activated partial thromboplastin time prolonged
- Meningococcal sepsis (meningococcal infection to whole body)
- Overdose
- Renal impairment (severely reduced kidney function)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Septic shock (shock due to blood infection)
- Thrombocytopenia (decrease of platelets in blood)
- White blood cell count decreased
- Blood creatinine decreased
What are the common drug interactions of Piperacillin and Xigris, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Respiratory failure (inadequate gas exchange by the respiratory system)
30-39:
n/a
40-49:
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Renal impairment (severely reduced kidney function)
50-59:
- Activated partial thromboplastin time prolonged
- Blood creatinine decreased
- Epistaxis (bleed from the nose)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- International normalised ratio increased
- Mouth haemorrhage (bleeding from mouth)
- Platelet count decreased
- White blood cell count decreased
- White blood cell count increased
60+:
- Grand mal convulsion (a type of generalized seizure that affects the entire brain)
- Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
- Overdose
- Thrombocytopenia (decrease of platelets in blood)
- White blood cell count increased
- Septic shock (shock due to blood infection)
- Activated partial thromboplastin time prolonged
- Anuria (failure of the kidneys to produce urine)
- Cardiac arrest
- Catheter site haemorrhage (bleeding at catheter site)
What are the existing conditions these people have? *
- Sepsis (a severe blood infection that can lead to organ failure and death): 8 people, 57.14%
- Sedation: 1 person, 7.14%
- Pain: 1 person, 7.14%
- Multi-Organ Failure (multisystem organ failure): 1 person, 7.14%
- Meningococcal Sepsis (meningococcal infection to whole body): 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Piperacillin and Xigris?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Piperacillin (5,597 reports)
- Xigris (3,542 reports)
Browse all drug interactions of Piperacillin and Xigris:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Piperacillin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Xigris:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Piperacillin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Xigris and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on piperacillin sodium and drotrecogin alfa (activated) (the active ingredients of Piperacillin and Xigris, respectively), and Piperacillin and Xigris (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Dupixent cause Dyshidrotic Eczema? - a second ago
- High Blood Pressure and Blood Phosphorus Increased - 3 seconds ago
- Deltasone and Calcium Citrate drug interactions for men aged 60+ - 6 seconds ago
- Hypermagnesaemia and drugs of ingredients of metoclopramide hydrochloride - 11 seconds ago
- Cimzia and Spinal Column Stenosis for Women aged 60+ - 11 seconds ago
- Ondansetron and Nosebleed for Men aged 50-59 - 14 seconds ago
- Ondansetron and Nose Bleed for Men aged 50-59 - 14 seconds ago
- Ondansetron and Nose Bleeds for Men aged 50-59 - 15 seconds ago
- Ondansetron and Epistaxis for Men aged 50-59 - 15 seconds ago
- Ondansetron and Bleeding From The Nose for Men aged 50-59 - 15 seconds ago